Some of the big companies in the biotech sector have already outlined their plans for the new phase. For now, the largest U.S. biotech companies have...
With the $57 million (€50 million), SpliceBio aims to bring this strategy to the clinical phase (human trials) in about 2 to 3 years. Its aim...